Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Brahmi (Bacopa monnieri) has a long-standing history of use in Ayurvedic medicine for promoting cognitive function, reducing anxiety, and supporting mental health. The term "neurosis" is somewhat outdated in modern psychiatry, now replaced by more specific diagnoses such as anxiety disorders and obsessive-compulsive disorders. Several preclinical and clinical studies have investigated Bacopa monnieri for its anxiolytic (anxiety-reducing) and adaptogenic properties. Some randomized controlled trials suggest that Brahmi may modestly reduce symptoms of anxiety and improve cognitive function in adults. The proposed mechanisms involve modulation of neurotransmitters such as serotonin and dopamine, and antioxidant effects in the brain.

However, while there is some scientific validation for Brahmi's effects on anxiety and stress—which are central components of what was historically termed "neurosis"—direct high-quality evidence for Brahmi's efficacy in treating neurosis as a clinical entity is limited. Most studies are small, short-term, and there is considerable heterogeneity in study design. Meta-analyses and systematic reviews note the need for larger, well-controlled trials.

In summary, Brahmi's use for neurosis is supported by traditional use and some scientific evidence, primarily relating to symptoms of anxiety and cognitive dysfunction. The overall quality and quantity of evidence warrant a moderate rating, acknowledging both promising results and the need for further research.

More about Brahmi
More about Neurosis

Other ingredients used for Neurosis

Other health conditions supported by Brahmi

Products containing Brahmi